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Axon regeneration in the CNS requires reactivating
injured neurons’ intrinsic growth state and enabling
growth in an inhibitory environment. Using an inbred
mouse neuronal phenotypic screen, we find that
CAST/Ei mouse adult dorsal root ganglion neurons
extendaxonsmoreonCNSmyelin than theother eight
strains tested, especially when pre-injured. Injury-
primed CAST/Ei neurons also regenerate markedly
in the spinal cord and optic nerve more than those
from C57BL/6 mice and show greater sprouting
following ischemic stroke. Heritability estimates indi-
cate that extended growth in CAST/Ei neurons on
myelin is genetically determined, and two whole-
genome expression screens yield the Activin tran-
script Inhba as most correlated with this ability.
Inhibition of Activin signaling in CAST/Ei mice dimin-
ishes their CNS regenerative capacity, whereas its
activation in C57BL/6 animals boosts regeneration.
This screen demonstrates that mammalian CNS
regeneration can occur and reveals a molecular
pathway that contributes to this ability.
INTRODUCTION
Axons do not regenerate after an injury to the adult mammalian
CNS. Two conditions appear to be required for successful re-
growth of injured CNS axons: an intrinsic capacity of the neurons
to grow and an ability to overcome growth-inhibitory environ-
ments. Many factors inhibit growth in the CNS (Filbin, 2003; Fitch
and Silver, 2008; Fournier et al., 2001; Silver et al., 2014), and
eliminating some of these can promote regeneration (Alilainet al., 2011). In the mature CNS the intrinsic growth capacity of
intact neurons is repressed to stabilize synaptic circuitry (Sun
and He, 2010) and is not generally re-engaged after axonal injury
(Cho et al., 2013). To experimentally increase intrinsic neuronal
growth in the CNS, studies have genetically inhibited growth-
suppressing genes (Sun et al., 2011), exposed CNS neurons to
growth-promoting factors (Yin et al., 2006), and altered the
neuronal growth state by a pre-conditioning axonal lesion (Ka-
doya et al., 2009; Mills et al., 2007; Neumann and Woolf,
1999). The data from many studies suggest that both the pres-
ence of extrinsic inhibition and the lack of an intrinsic growth ca-
pacity after injury are important in preventing axonal re-growth in
adult CNS (Benowitz and Yin, 2007).
Neurons with axons in the peripheral nervous system retain an
ability to regenerate following injury by inducing a robust intrinsic
growth response; in addition, the PNS environment is growth
permissive (Hoffman, 2010). Pre-conditioning PNS neurons by a
peripheral axonal injury primes them through massive transcrip-
tional changes to regenerate more vigorously and faster in the
face of a second injury because of an induction of networks of
regeneration-associated genes (Tedeschi, 2012). Such pre-
conditioned growth can be detected in vitro both on permissive
substrates (Smith and Skene, 1997; Richardson and Issa, 1984)
and toamore limiteddegreeonmyelin, the latter enabling thecen-
tral axons of pre-conditioned neurons to begin to grow in theCNS
(Kadoyaet al., 2009;Mills et al., 2007;NeumannandWoolf, 1999).
Studies of the transcriptional response in pre-conditioned dor-
sal root ganglia (DRG) neurons have implicated regeneration-
promoting roles for many transcription factors (c-Jun, Atf3, Klf
family, Stat3, Sox11, and Smad1) and regeneration-associated
genes (Gap43, Cap23, Arg1, Sprr1a, Hspb1, and tubulins; re-
viewed in Sun and He, 2010; Tedeschi, 2012). In retinal ganglion
cells (RGCs) a growth-priming phenomenon analogous to pre-
conditioning can be initiated by intraocular inflammation using
agents such as zymosan, which activates expression of the
neutrophil- andmacrophage-derived growth factor oncomodulinNeuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc. 1215
to increase neuronal expression of regeneration-associated
genes (Benowitz and Popovich, 2011; Kurimoto et al., 2013).
Using an adult primary neuron cell-based assay in genetically
diverse inbred mouse strains, we have investigated whether the
capacity for adult sensory neurons to regenerate on an inhibitory
substrate after a pre-conditioning lesion has a heritable compo-
nent, with the intention of then using this for identifying signaling
pathways that may enable growth of injured CNS neurons. Our
results identify a particular mouse strain with the capacity to
regenerate injured axons in the CNS to a far greater extent
than other inbred strains and also identify Activin signaling as a
major component of this ability.
RESULTS
In Vitro Screening for Heritability of DRG Neuron Axonal
Growth on Central Myelin
We examined nine diverse inbred mouse strains for a potential
differential capacity to initiate adult axonal growth in a CNS-
like environment. To accomplish this we screened adult primary
sensory neurons obtained from the lumbar L4 and L5 DRGs of
genetically distinct mouse strains (A/J, C3H/HeJ, C57BL/6J,
DBA/2J, 129S1/SvImJ, NOD/LtJ, NZO/HlLtJ, CAST/EiJ, and
WSB/EiJ) for their ability to extend neurites when grown in cul-
ture on CNS myelin over 24 hr, as a model for axonal growth in
the face of the inhibitory CNS environment. The genetic diversity
of the nine strains, which are founder members of the Collabora-
tive Cross, has been well documented (Chesler et al., 2008). The
uninjured central branch of DRG neurons can regenerate to
some extent in the spinal cord in spite of the inhibitory growth
environment when the peripheral axons of these cells are pre-
injured (Kadoya et al., 2009; Mills et al., 2007; Neumann and
Woolf, 1999). Consequently, the axonal outgrowth screens on
myelin were performed using both naive (DRG neurons from
uninjured mice) and pre-conditioned neurons (DRG neurons
pre-injured by a sciatic nerve crush 5 days before culture).
These assays revealed that DRG neurons from CAST/Ei
mice were capable of producing substantially higher levels of
growth on a myelin substrate than all the other strains assayed,
measured both as numbers of neurons with neurites and longest
axonal process per neuron. The axonal growth in this strain sur-
passed the average growth of the other strains under naive con-
ditions (2-fold increase, p < 0.01, one-way ANOVA; post hoc
Sidak’s, for naive CAST/Ei against all other naive strains) and
was markedly greater than the average growth of the other
strains after pre-conditioning (3.5-fold increase, p < 0.0001,
one-way ANOVA; post hoc Sidak’s, for conditioned CAST/Ei
against all other pre-injured strains; Figures 1A–1C). Pre-condi-
tioning increased growth on myelin in all the strains, but the rela-
tive increase in effect size wasmuch greater for neurons from the
CAST/Ei strain (Table S1). The low-power micrographs pre-
sented in Figure 1 show the extent of this growth in pre-injured
CAST/Ei neurons, a finding that was replicated multiple times
(see Experimental Procedures).
The sensory neurons from the CAST/Ei mice also exhibited
elevated levels of growth compared to those from C57BL/6
mice when grown on chondroitin sulfate proteoglycans (CSPGs),
an inhibitory substrate found in glial scars (Dickendesher et al.,1216 Neuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc.2012; Fisher et al., 2011; Shen et al., 2009). Pre-conditioned
CAST/Ei neurons grew far more robustly than pre-conditioned
C57BL/6 neurons on both CSPGs (4-fold increase, p < 0.05,
56.7 [17.0]; CI, 8.3–105.1; three-way ANOVA; post hoc Sidak’s)
and onmyelin (as an independent replicate of the earlier findings;
4.1-fold increase, p < 0.001, 68.7 [17.0]; CI, 20.3–117.1; three-
way ANOVA; post hoc Sidak’s; Figure 1E). These results show
that injury-conditioned CAST/Ei DRG neurite growth is strikingly
greater than that of conditioned C57BL/6 on two major CNS-
inhibitory substrates, myelin and CSPGs, indicating a broad
reduction in responsiveness of sensory neurons from this strain
to potent CNS inhibitory cues.
In contrast, pre-conditioned growth on permissive substrates
(dissociated DRG neurons on laminin, whole adult DRG explants
on matrigel, and also within the PNS in vivo after a sciatic nerve
crush) was broadly similar between CAST/Ei and C57BL/6 (1.3-
fold CAST/Ei pre-conditioned versus C57BL/6 pre-conditioned
at 12 hr on laminin; p < 0.001; one-way ANOVA; post hoc Si-
dak’s; Figure S1B). These results imply that DRG neurons from
CAST/Ei mice activate a growth program when injured that spe-
cifically enables extensive axonal regeneration on CNS inhibitory
substrates, and that this differs from the generalized ‘‘pre-condi-
tioning effect’’ present across all the lines, which promotes
regeneration strongly on permissive substrates or in the PNS,
but only to a much more limited extent on myelin or in the CNS.
Growth Phenotype of Injured CAST Neurons in the CNS
Todeterminewhether thegrowthcapacityof injuredCAST/EiDRG
sensory neurons on myelin and CSPGs translates into enhanced
growth in the CNS, we assayed three different animal models of
CNS regeneration: dorsal column injury, optic nerve (ON) injury,
and ischemicstroke.Wefirst assayed regenerationof thecentrally
projectingDRGsensory axons inCAST/Ei orC57BL/6miceafter a
dorsal column injury at T10, with and without a pre-conditioning
lesion to the sciatic nerve. This is an established model of DRG
axonal growth in the CNS, in which the pre-conditioning enables
some regeneration of central axons of DRG neurons in the injured
spinal cord to occur (Kadoya et al., 2009; Mills et al., 2007; Neu-
mann and Woolf, 1999). Both strains received either a sham or
sciatic nerve pre-conditioning injury a week prior to the dorsal
column injury at T10. At 6 weeks after the dorsal column injury
the sciatic nerve was re-exposed and injected with dextran 3000
(micro-Ruby) to retrogradely label ascendingdorsal columnfibers,
and these were measured 2 weeks later.
Axonal growth in the dorsal column after a lesion was very
limited inbothC57BL/6andCAST/Eimice that hadnot undergone
a pre-conditioning lesion; however, the pre-conditioning of sen-
sory neurons prior to the spinal cord injury resulted in growth
into and beyond the lesion site in both strains (Figures 2A, 2B,
S2, and S3). In these mice the dorsal columns from the condi-
tioned CAST/Ei mice contain significantly more regenerating
axonal trajectories quantified up to 3 mm rostral of the injury site
thanpre-injuredC57BL/6mice (p = 0.004; differencesdetermined
bypermutation tests forCAST/Ei andC57BL/6axonal growthpro-
files; Figure 3E). Overall pre-conditioned CAST/Ei sciatic dorsal
column fibers regenerated 2,974 ± 89 mm rostral from the lesion
site compared to 789 ± 271 mm in C57BL/6 (a 3.5-fold difference,
p < 0.01, 2,184.9 [557.1] CI 826.3–3,543.6; two-way ANOVA; post
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Figure 1. Screening for Axonal Growth in an Inhibitory Central Growth Environment
(A) Representative photomicrographs of pre-conditioned axonal growth for nine screenedmouse strains (A/J, C3H/HeJ, C57BL/6J, DBA/2J, 129S1/SvImJ, NOD/
LtJ, NZO/HlLtJ, CAST/EiJ, and WSB/EiJ) on myelin.
(B) Maximal level of axonal sprouting achieved by naive and pre-conditioned DRG neurons grown on myelin for 24 hr in these mouse strains.
(C) Maximal level of axonal outgrowth achieved in naive and pre-conditioned DRG neurons by a sciatic nerve crush injury 5 days prior to growth on myelin
for 24 hr.
(D) Representative photomicrographs of pre-conditioned DRG axonal growth for C57BL/6 and CAST/Ei DRG neurons on PDL, myelin, and CSPGs, respectively.
(E) Quantification of growth of naive and pre-conditioned C57BL/6 and CAST/Ei DRG neurons on a neutral substrate, poly-d-lysine, and on inhibitory substrates,
myelin and CSPGs. Alternate image capture and counting schemes were used between data given in (A)–(C), (D), and (E) (see Experimental Procedures). All error
bars represent SEM. Statistical analysis of (B) and (C): one-way ANOVA; post hoc Sidak’s corrected, p < 0.0001 for pre-conditioned CAST/Ei against all other
conditions. For (E): three-way ANOVA; post hoc Sidak’s. **p < 0.01; ****p < 0.0001. Scale, 100 mm. For growth of C57BL/6 and CAST/Ei DRG neurons in the PNS
see Figure S1.hoc Sidak’s; Figure S4). In two out of seven CAST/Ei animals,
axonal growth reached 5 mm beyond the crush site. The limited
extent of growth rostral to the injury site in C57BL/6 mice was
consistent with previous results (Seijffers et al., 2007).
We next investigated whether CAST/Ei neurons that lie entirely
within the CNS would also show enhanced regenerative growth.
To do this, we assayed RGC axon regeneration after ON crush
using cholera toxin B fragment (CTB) as an axonal tracer. Axon
regeneration under baseline conditions was minimal in both
strains 2 weeks after ON crush. Zymosan is commonly used to
condition these cells in a manner analogous to a priming nerve
injury for DRG neurons (Yin et al., 2003), with a dose of 36 mg
zymosan optimal for promoting RGC regeneration in C57BL/6mice (Kurimoto et al., 2010; Yin et al., 2006). To compare relative
regeneration between the two strains we tested the effects of
two reduced doses of zymosan applied 5 days before and imme-
diately after the ON crush, in order to induce a lower-than-
maximal growth in C57BL/6 mice.
In C57BL/6 animals 6.4 mg and 25 mg of zymosan produced
modest and dose-dependent levels of axonal regeneration
measured 14 days after the ON injury (Figures 3A and 3B) (Kur-
imoto et al., 2010; Yin et al., 2006). The same doses in CAST/
Ei mice, however, produced substantially more extensive axonal
regeneration, with axons observed as far as 4,000 mm from the
crush site reaching close to the optic chiasm. Differences were
determined by permutation tests for contrast based on averageNeuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc. 1217
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Figure 2. CAST versus C57 Axonal Regeneration in the Adult
Spinal Cord
(A and B) Regeneration of central axons of pre-conditioned DRG neurons
rostral to a dorsal column injury. A small level of growth is present in C57BL/6
mice (A), but it is significantly greater in CAST/Ei mice (B). Growth quantified in
Figure 3. Arrows identify retrogradely labeled axons from the PNS. The white
dashed line indicates the border of the lesion. Asterisk indicates the lesion
epicenter (R, rostral; C, caudal). The images are automated tile-scanned
confocal images using a Zeiss LSM 700 confocal microscope, and two
consecutive sections (20 mm each) were overlaid and aligned. Scale, 100 mm.
See also Figures S2 and S3.difference of regenerating axonal trajectories; at 6.4 mg zymosan
CAST versus C57, mean difference, 118.02, p = 0.012; at 25 mg
zymosan CAST versus C57, mean difference, 93.28, p = 0.031
(Figures 3C and 3D, quantified in Figure 3F). As robust growth
occurred in CAST/Ei RGCs at a low dose of zymosan (6.4 mg),
one at which C57BL/6 RGCs respond minimally, these results
suggest that CAST/Ei CNS neurons are either primedmore easily
for re-growth than those from C57BL/6 mice or overcome inhib-
itory substrates better.
Next, we assayed whether CAST/Ei mice exhibit a greater
axonal sprouting ability than C57BL/6 mice following an1218 Neuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc.ischemic stroke produced by middle cerebral artery occlusion,
where neuronal growth is impeded by myelin and CSPGs. To
determine the extent of axonal sprouting we mapped cortical
motor system connections in naive CAST/Ei and C57BL/6 mice
1 month after stroke, a time point that coincides with the forma-
tion of new connections (Clarkson et al., 2013; Li et al., 2010;
Overman et al., 2012). In C57BL/6 animals, motor cortex projec-
tions showed only a limited degree of axonal sprouting (Figures
4A and 4B). However, sprouting in CAST/Ei mice extended from
the motor cortex into the premotor cortex, as well as to posterior
and lateral areas corresponding to the first and second
somatosensory cortices (Figures 4C and 4D), with axonal projec-
tions > 5 mm from cell bodies (43% area increase in CAST/Ei
stroke 16.55 ± 1.9 mm2 versus C57BL/6 stroke 11.58 ±
1.0 mm2, p < 0.05, Student’s t test, two-tailed, Figure 4E) (Clark-
son et al., 2013; Li et al., 2010; Overman et al., 2012). Pre-condi-
tioning by axonal injury or zymosan administration was not
necessary in this model to achieve enhanced axonal regenera-
tion in the CAST/Ei mice, perhaps because the inflammation
intrinsic to this model is sufficient to prime the cortical neurons
for growth, and possibly, in part, because the axons do not
have to traverse a physical lesion, as in the spinal cord and ON
CNS injury models.
Heritability Estimates of Axonal Growth Phenotype
We next wished to understand what molecular signaling path-
ways might operate in CAST/Ei mouse neurons to enable regen-
eration in a CNS environment and if these are genetically deter-
mined. To estimate the genetic contribution to the observed
regenerative variance across strains we estimated narrow-sense
heritability, defined as the additive contribution of genetic factors
to the observed phenotype from normalized phenotypic data
across all nine strains (Table S2). Pre-conditioned growth on
myelin showed a high degree of heritability, 72% (p = 2.2 3
1014) for axonal length, suggesting that most of the inter-strain
axonal growth variation can be attributed to genetic factors.
Genome-wide Expression Profiling of Naive and
Pre-conditioned DRGs across All Nine Strains
Given the high heritability, we undertook two bioinformatic stra-
tegies to identify candidate genes and pathways that may
contribute specifically to the CAST/Ei pre-conditioned growth
on myelin phenotype. In the first, we performed a genome-
wide microarray expression profiling screen of naive and pre-
conditioned DRG tissue across all nine mouse strains (Table
S3). We then correlated this with the degree of DRG axonal
growth on myelin, and ranked the resulting genes by Pearson
correlation coefficient (Table S4). In the second strategy, we as-
sayed global transcript expression in naive and pre-conditioned
DRGs by RNA-seq from three strains chosen for their differing
regenerative capacity (C57BL/6, low; DBA/2, mid-range; and
CAST/Ei, high). This global expression dataset was then
compared to naive and pre-conditioned axonal growth onmyelin
using an independent screening assay (see Experimental Proce-
dures) to determine the genes that most closely correlated to
growth. Remarkably, in both bioinformatic analyses, Inhba was
revealed to be the transcript most strongly correlated with ability
of the pre-injured DRG neurons to grow on myelin (Figures 5A,
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Figure 3. CAST versus C57 Axonal Regeneration in the Adult CNS
(A–D) Optic nerve injury treated with low-dose (6.4 mg) zymosan in C57BL/6 results in minimal RGC re-growth (A), but the same dose initiates robust growth in
CAST/Ei (C). Medium-dose zymosan (25 mg) stimulates growth in C57BL/6 optic nerves (B); however, CAST/Ei RGC growth is much greater (D). Scale, 500 mm.
Red arrowhead signifies maximal axonal growth in that section. Inset, magnified image of the regenerating fibers. Scale, 25 mm. These images were obtained
using a Zeiss Spinning Disk Confocal at a magnification of 203, then automatically tiled using Volocity Image Analysis Software (PerkinElmer).
(E) Quantification of percentage of labeled axons crossing the injury site rostral to the lesion site in pre-conditioned adult C57BL/6 and CAST/Ei spinal cords,
respectively.
(F) Quantification of numbers of axons reaching defined distances from the crush site in the optic nerve injury model of central regeneration. C57BL/6 and CAST/
Ei 25 mg or 6 mg zymosan versus control comparisons; ***p < 0.001, ****p < 0.0001 (two-way ANOVA, post hoc Sidak’s). All error bars represent SEM. For
quantification of longest axonal growth in the injured spinal cord see Figure S4.5C, and 5D). The strain-dependent regulation of Inhba indicated
by the profiling studies (Figures 5A and 5E) was confirmed in in-
dependent samples across time by qRT-PCR (Figure 5F). As two
independent genome-wide screens identified Activin signaling
as being most highly correlated to CAST/Ei active growth on
myelin, we chose to investigate this cascade further as detailed
below. However, this is unlikely to be the only signaling system
that contributes to the CAST/Ei CNS growth phenotype, since
we identified two sets of other highly correlated transcripts (Fig-
ures 5A and 5D) from the full screen data.
Overall, the DRG gene expression levels in naive mice and the
transcriptional changes induced by sciatic nerve crushwere very
similar across the nine strains, with relatively few transcripts
showing large strain-dependent expression differences across
the dataset. To illustrate this, we performed a weighted gene
co-expression network analysis (WGCNA) (Oldham et al., 2008)
on the full mouse array dataset. Briefly, absolute Pearson corre-
lation coefficients between each transcript and every other gene
in the expression analysis were computed, weighted, and used
to determine the topological overlap, a measure of connection
strength, or ‘‘neighborhood sharing,’’ in the network. A set of
‘‘expression networks’’ were then constructed where the mem-
bers of each network have high topological overlap. Groups of
genes with very similar expression patterns across large data-
sets are often functionally connected being part of the same tis-
sue, cell type, or biological pathway (Oldham et al., 2006, 2008).Across the mouse array dataset the largest of these expression
networks (turquoise, n = 1,824 unique transcripts) represented
genes commonly expressed and regulated after nerve injury be-
tween the strains (Table S5). This gene set also overlapped sub-
stantially with that group of transcripts that is regulated in the rat
DRG following a sciatic nerve injury, and previously implicated as
contributing to the conditioning response (p value = 7.1 3 1052
at the 7-day time point) (Chang and Jovanis, 1990; Kadoya
et al., 2009). The turquoise ‘‘mouse pre-conditioning response’’
network did not include Inhba, which is uniquely induced in
CAST/Ei relative to marginal changes in expression in the other
strains. In addition, Inhba is not upregulated in the rat DRG
following sciatic nerve injury (Blesch et al., 2012; Costigan
et al., 2010). Moreover, when the degree of regulation of anno-
tated regeneration-associated genes (Sun and He, 2010; Tede-
schi, 2012) between C57BL/6 and CAST/Ei was analyzed, we
found virtually no difference (Figure S5). We interpret these
data as indicating that those elements of the pre-conditioning
transcriptional response that facilitate accelerated regeneration
in the PNS are largely uniform across all nine mouse strains, in
keeping with theminimal difference we found in growth rates be-
tween C57BL/6 and CAST/Ei on permissive substrates or in the
PNS (Figure S1). Our screen of pre-injured DRG neuronal growth
on central myelin has assayed a completely different genomic
program, one which enables primed CAST/Ei injured neurons
to grow robustly on CNS growth-inhibitory substrates.Neuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc. 1219
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Figure 4. CAST versus C57 Axonal Regen-
eration Post Cortical Stroke
(A) Connections of forelimb motor cortex in
C57BL/6 with and without stroke. Light blue dots
indicate the location of projections in non-stroke,
red in stroke, and dark blue dots are areas of
dense overlap between the two conditions. Gray
circle is site of tracer injection. The x and y axes
represent micron distance from the center of the
tracer injection. p value, Hotelling’s inverse t test.
(B) Polar distribution map in register with
connectional plot in (A) showing localization of
sprouting in stroke versus control (Watson’s U2
test; p < 0.05). Shaded polygons represent the
70th percentile of the distances of labeled pro-
jections from the injection site in each segment of
the graph; weighted polar vectors represent
normalized distribution of the quantity of points in
a given segment of control (blue) or stroke (red)
graphs.
(C) Same conventions as in (A) for CAST/Ei mice
(n = 5 per group). Note the connections in the far
premotor cortex, 4 to 5.5 mm anterior to the tracer
injection site. These are not present in C57BL/6
after stroke (arrows).
(D) Same conventions as in (B). Overlay of con-
trol and post-stroke forelimb motor cortex pro-
jections.
(E) Area of motor cortex projections in C57BL/6
and CAST/Ei mice. Areas taken from 70th
percentile of all distances in each radial segment
from the injection site (B and D). Student’s t test,
two-tailed. ^p < 0.05, non-stroke versus stroke
C57BL/6 (n = 5 for both stroke and non-stroke)
and CAST/Ei (n = 5 for both stroke and non-
stroke), respectively; *p < 0.05, CAST/Ei stroke
versus C57BL/6 stroke. All error bars represent
SEM. See Supplemental Experimental Pro-
cedures for further details.Activin Signaling Components in C57 and CAST DRGs
Inhba mRNA encodes Activin-bA, and the Activin signaling
cascade is a component of the TGF-beta superfamily. Activin
comprises three functional protein forms, Activin-A (bAbA),
Activin-B (bBbB), and Activin-AB (bAbB). The Activin-bB transcript
Inhbb, unlike Inhba, was upregulated to a similar extent in CAST/
Ei and C57BL/6 DRGs following sciatic nerve crush injury (Fig-
ure 5F). Activin is signaled by one type I serine/threonine kinase
receptor (Acvr1b, Alk4) and two type II co-receptors (Acvr2a
and Acv2b) (Harrison et al., 2003). These receptors form
an active tetrameric complex composed of two of each
receptor subtype. Acvr1b is expressed at higher levels in naive1220 Neuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc.CAST/Ei DRGs than in C57BL/6 DRGs
(13.2-fold), but is not regulated by nerve
injury. In C57BL/6 DRGs, levels of this
transcript are low in the naive state, but
it slowly upregulates following injury.
Both type II receptors are expressed at
higher levels in naive CAST/Ei than
C57BL/6 DRGs and were minimally regu-
lated by injury in either strain (Figure 5F).Using in situ hybridization and immunohistochemistry we
demonstrate that InhbamRNA, the Activin-bA peptide, and all re-
ceptor subtypes are expressed in injured CAST/Ei DRG neurons.
Furthermore, we confirm lack of Inhba mRNA induction and
Activin-bA peptide expression in injured C57BL/6 DRG neurons
(Figure S6).
Activin signaling promotes translocation of phosphorylated
Smad2/3 from the cytoplasm to the nucleus to initiate down-
stream transcriptional signaling, and we found a large increase
in nuclear phospho-Smad2/3 in pre-conditioned DRG neurons
from CAST/Ei, but not C57BL/6, mice (Figure S5). Thus, pre-
conditioned CAST/Ei, but not C57BL/6, neurons manifest
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Figure 5. Genome-wide Expression Analysis of CAST CNS Growth
(A) Naive and pre-conditioned array data for the 15 genes whose DRG expression behavior most correlated with axonal growth on myelin. Each box represents
data from a single array, each column a single DRG sample, each row a single gene, blue is less expressed, and red ismost expressed. The transcripts are listed in
order of Pearson correlation coefficient between expression and axonal growth, and the strains are ordered relative to pre-conditioned growth on myelin.
(B) The growth phenotype of each strain measured in a follow-up RNA-seq screen determined by maximal axonal length. Horizontal red checked line represents
the minimal growth level required in the screen for strong growth in the CNS.
(C) Expression data of the 16 genes identified by RNA-seq screen. These data highlight the Inhba transcript expression (red line) as the most related to long-
distance regeneration in the mammalian CNS.
(D) Each of the transcripts identified by the screen with the color indicator for the expression profiles shown in (C).
(E) Actual expression of the Inhba transcript measured by RNA-seq (units are counts per million reads); Inhba expression is significantly upregulated after pre-
conditioning only in the DBA/2 and CAST/Ei strains (*p < 0.01, false-discovery rate < 0.01, edgeR). Data from two independent screens then place Activin
signaling at the apex of the strong central axonal regeneration phenotype, most clearly seen in the CAST/Ei strain.
(F) Time course of expression of Inhba, Inhbb, and Activin receptor subtype transcripts in ipsilateral L4/L5 DRG from naive mice and 1, 3, 5, 10, and 14 days post-
sciatic nerve crush for both C57BL/6 and CAST/Ei. qRT-PCR; mean fold change ± SEM normalized to naive C57BL/6 values. For statistical analysis, two-way
ANOVA was performed, post hoc Sidak’s (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). All error bars represent SEM. For Activin cascade member sites of
expression in the DRG see Figure S5.activation of downstream signaling components of the Activin
pathway.
Activin Gain and Loss of Function
ToevaluatewhetherActivin signaling is necessary for the elevated
axonal growth of CAST/Ei DRG neurons on myelin, we cultured
pre-conditionedCAST/Ei DRG neurons for 24 hr (the same proto-
col used for screening inbred strains) in the presence or absenceof SB-431542, a potent Activin receptor antagonist (Laping et al.,
2002). SB-431542 (100 nM) significantly reduced neurite initiation
(42% reduction, p < 0.0001, 22.3 [2.6] CI, 15.6–28.9; two-way
ANOVA, post hoc Sidak’s) and maximal axon length (48% reduc-
tion, p < 0.0001, 232.7 [21.9] CI, 176.6–288.9; two-way ANOVA,
post hoc Sidak’s) relative to vehicle controls (Figures 6A–6C).
We also determined whether exogenous introduction of Acti-
vin ligands could promote axonal growth on myelin in C57BL/6Neuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc. 1221
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Figure 6. Gain- and Loss-of-Function Assays
of Activin Action in Promoting Central Axonal
Growth
(A–C) The Activin receptor, type IB inhibitor SB-
431542 (100 nM), significantly decreases neuronal
growth of pre-conditioned CAST/Ei DRG neurons
on myelin, quantified in (B) and (C).
(D–F) A mixture of Activin-A, Activin-B, and Activin-
AB peptides (10 ng/ml) significantly increased
axonal growth in pre-conditioned C57BL/6 DRG
neurons, quantified in (E) and (F). Neuronal counts
average of four wells per group, run three inde-
pendent times as counted in Figures 1A–1C. For (B),
(C), (E), and (F): mean ± SEM. ****p < 0.0001 (two-
way ANOVA, post hoc Sidak’s). Scale, 100 mm. All
error bars represent SEM.neurons. Dissociated pre-conditioned DRG neurons from
C57BL/6 mice showed a 10.6-fold increase in sprouting (p <
0.0001, 24.1 [2.2] CI, 18.8–29.4; two-way ANOVA, post hoc Si-
dak’s) and a 3.6-fold increase in neurite elongation (p < 0.0001,
135.6 [19.8] CI, 88.1–183.1; two-way ANOVA, post hoc Sidak’s)
on myelin when cultured in the presence of Activin A, B, and AB
peptides (10 ng/ml; Figures 6D–6F). To monitor Activin down-
stream signaling in these cells, we assayed nuclear pSmad2/3
localization, finding low overall levels in C57BL/6 naive neurons
(4.4% positive nuclei) with significantly more, but still relatively
low, levels in pre-conditioned C57BL/6 neurons (21% positive
nuclei, p < 0.05, 0.19 [0.05] CI, 0.03–0.35; Poisson regression,
rate estimate on a log scale, post hoc Sidak’s) that increased
robustly when treated with Activin to 56% nuclear staining (p <
0.0001, 0.59 [0.06] CI, 0.39–0.79; Poisson regression, rate esti-
mate on a log scale, post hoc Sidak’s). Nuclear pSmad2/3 levels
were relatively high in naive dissociated CAST/Ei DRG neurons
at 46%, but increased further after pre-conditioning to 69%
(p < 0.0001, 0.53 [0.08] CI, 0.27–0.79; Poisson regression, rate
estimate on a log scale, post hoc Sidak’s). In addition, the num-
ber of pSmad2/3-stained nuclei decreased from 69% to 45%
when pre-conditioned CAST/Ei neurons were treated with SB-
431542 (100 nM) (p < 0.0001, 0.56 [0.08] CI, 0.31–0.81; Poisson
regression, rate estimate on a log scale, post hoc Sidak’s; Fig-
ures 7A and 7B).
Zymosan at a dose (6.4 mg) that produces extensive growth
only in CAST/Ei mice induced Inhba mRNA expression in the
retina of this strain, but not in retina fromC57BL/6mice, whereas
a higher zymosan dose (25 mg), which promotes regeneration in
both strains, induced Inhba mRNA expression in both mouse
lines (Figure 7C). To test if Activin signaling can boost RGC
axonal regeneration in vivo we measured axonal growth in
C57BL/6 ONs after crush where the retina had been treated
with low-dose (6.4 mg) zymosan and then with 10 ng/ml of Activin
immediately after ON crush. This combination resulted in a 4.2-1222 Neuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc.fold increase in the number of axons
500 mm distal to the crush site relative to
zymosan alone (p < 0.05, 112.4 [39.5] CI,
14.9–209.9; two-way ANOVA, post hoc
Sidak’s; Figure 7D), showing that Activin
enhanced CNS axonal regeneration inC57BL/6 mice after a low-dose zymosan priming. Finally, we as-
sayed if Activin promoted CNS neuron growth in another species
using rat RGCs in culture. Rat RGCs that had been injured and
primed in vivo with low-dose zymosan (6.4 mg) showed a 2.8-
fold increase in outgrowth when subsequently grown on PDL
in vitro in response to the addition of Activin peptides (relative
to control RGCs, p < 0.01, Student’s t test, two-tailed; Figure S7).
DISCUSSION
Neurons in the adult mammalian PNS have the capacity, also
found in the CNS of some lower organisms, to mount a regener-
ative response following axonal damage. In stark contrast, this
regenerative ability has been considered to be essentially lost
in the mammalian adult CNS. Two factors have been considered
cardinal to achieving long-distance axonal growth in the adult
mammalian CNS: removal of the growth-inhibitory environment
and initiation of intrinsic molecular growth programs that enable
active axonal growth. Our data show that CAST/Ei mouse neu-
rons, following a pre-conditioning injury, are not inhibited by
extrinsic inhibitory cues from the CNS extracellular environment
in the way that other mouse strains are. The extent of the CNS
regeneration in primed RGCs from CAST/Ei mice (as determined
by maximal axonal growth) is similar to that found when tonic
growth suppressors are eliminated (Gaub et al., 2010; Sun
et al., 2011). The discovery of this unexpected growth capacity
of injured neurons in the CNS in this strain allows molecular
mechanisms required to initiate and sustain regeneration in
the adult mammalian CNS to be teased out, and therapeutic
implications of growth studies in these mice will aid drug discov-
ery without removal of tumor suppressor mechanisms, which
although effective, carry an oncogenic risk (Sun et al., 2011).
We designed a cell-based phenotypic screen to look for heri-
table differences in neuronal growth capacity, using pre-condi-
tioned DRG neurons on myelin to model one of the very few
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Figure 7. Molecular Mechanisms of Activin
Function
(A) Representative cultured pre-conditioned
C57BL/6 and CAST/Ei DRG neurons immuno-
stained for pSmad2/3 and Tuj1 before and after
Activin or SB-431542 treatment. Scale, 100 mm.
(B) Quantification of nuclear pSmad2/3 in naive
and pre-conditioned C57BL/6 and CAST/Ei DRG
neurons treated with Activin or SB-431542.
(C) qPCR data showing that treating the mouse
retina with 6.4 mg intraocular zymosan increases
Inhba mRNA expression only in CAST/Ei, while
25 mg induces regulation in both C57BL/6 and
CAST/Ei animals. Intraocular injection of 6.4 mg and
25 mg zymosan showing similar Inhbb regulation in
C57BL/6 and CAST/Ei animals.
(D) A mixture of Activin-A, Activin-B, and Activin-
AB increases ON regeneration in C57BL/6 mice
treated with 6.4 mg of zymosan. Data quantified as
numbers of optic nerve axons growing 500 mm and
1,000 mm from crush site in presence of PBS or
Activin peptide mix, respectively. For (B): mean ±
SEM. Statistical analysis Poisson regression, post
hoc Sidak’s. *p < 0.05, ****p < 0.0001. For (C): mean
fold change ± SEM normalized to naive C57BL/6
values, for comparisons shown *p < 0.05, **p <
0.01, ***p < 0.001 (two-way ANOVA, post hoc
Sidak’s). For (D): counts are average of four sections per animal, five animals. Average numbers of axons reaching defined distances from the crush site in each
animal ± SEM; *p < 0.05 (two-way ANOVA, post hoc Sidak’s). All error bars represent SEM. For in vitro gain-of-function assay using Activin peptides on rat retinal
ganglion cells see Figure S7.situations where axonal growth occurs in the CNS without ge-
netic manipulation: namely when a prior peripheral nerve injury
enables dorsal column fibers to regenerate into and beyond a
spinal cord injury (Lu et al., 2004; Neumann et al., 2002; Neu-
mann and Woolf, 1999). Our hypothesis was that differences in
the growth of isolated DRG neurons across different mouse
strains on a CNS inhibitory substrate might predict a differential
capacity to growwithin a CNS environment. Our screen revealed
both that there is a large heritable component to the regeneration
on myelin phenotype after pre-conditioning, and that CAST/Ei
display a much higher level of growth in this circumstance than
all the other strains. Furthermore, the growth of DRG neurons
from this strain in vitro in this model accurately predicted
increased growth in vivo of pre-conditioned dorsal column fibers
after a spinal cord injury, RGC axons after ON crush when
primed by zymosan, and enhanced spatial reorganization of
projections arising from cortical neurons after a stroke.
To successfully regrow after axonal injury, PNS neurons need
to realign their genomic structure through epigenetic mecha-
nisms (Cho et al., 2013; Finelli et al., 2013; Kiryu-Seo and
Kiyama, 2011; Puttagunta et al., 2014) to engage transcriptional
programs with miRNAs (Li et al., 2012) and signaling pathways
(Perry et al., 2012) to activate complex networks of transcription
factors and repressors (Costigan et al., 2002, 2010; Tedeschi,
2012). This injury response leads to the upregulation of the
many genes required for initiating, guiding, and sustaining axonal
growth. Injuring the central axons of these DRG neurons, how-
ever, has no such effect (Ylera et al., 2009). Essentially, periph-
eral nerve injury reprograms adult sensory and motor neurons
from a quiescent to an active intrinsic axonal growth mode, but
these changes are not a dedifferentiation to an immature state,since most of the genes induced are not developmentally regu-
lated. The increased intrinsic growth in DRG neurons after a
peripheral axonal injury is accompanied by somewhat reduced
responses to inhibitory cues, such as central myelin (Qiu et al.,
2002). As such large-scale transcriptional reprogramming does
not occur after axonal injury in CNS neurons (Cho et al., 2013),
this has been thought to be an important contributor to the failure
of CNS regeneration. We found that both C57BL/6 and CAST/Ei
neurons display increased growth in a permissive environment
after pre-conditioning, in agreement with multiple previous
studies in rats and mice (Richardson and Issa, 1984; Smith and
Skene, 1997), and that the extent of CAST/Ei pre-conditioned
growth in the PNS was not markedly different from that in
C57BL/6 mice. In keeping with this, the major component of
the transcriptional response to peripheral axonal injury (consti-
tuting pre-conditioning) was essentially identical across strains.
Therefore, an augmented or different transcriptional growth
response after conditioning could not account for the superior
regenerative capacity found for DRG neurons from CAST/Ei
mice on myelin, opening up the possibility that the pre-condi-
tioned growth on myelin phenotype results from a more discrete
process, specifically activated in this strain by injury, which
may add to the more generic pre-conditioned response that is
uniform across strains. CAST/Ei mice seem to engage, after
pre-conditioning in the case of DRG neurons or zymosan priming
for RGCs, a specific transcriptional mechanism distinct from the
standard induction of RAGs, which enables them to growwell on
myelin and CSPGs, and within the CNS in vivo.
Our bioinformatic analysis for differential transcript expression
correlates of the growth on myelin phenotype showed that in-
duction of Activin-bA was a prime candidate. In naive CASTNeuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc. 1223
DRG neurons, expression of transcripts that encode Activin-bA
and Activin-bB peptides (Inhba and Inhbb) is low, but the expres-
sion of the Activin receptors is high. Following axonal injury,
expression of Inhba and Inhbb mRNAs are upregulated, with
the increase in Inhba being specific to CAST/Ei mice and leading
to a markedly greater neuronal pSmad2/3 activation. How Acti-
vin signaling is selectively enhanced after injury in the CAST/Ei
strain relative to the others, and the transcriptional cascades
downstream of pSmad2/3 that increase axon growth and/or
reduce responses to CNS inhibitory cues, will now need to be
elucidated. Future work, for example, by assaying growth varia-
tion on myelin in collaborative cross-recombinant backcross
strains (Threadgill et al., 2011), could help define the complete
genomic pathway required for this growth phenotype.
To test if Activin-bA mechanistically contributed to the CNS
regeneration phenotype, we used gain- and loss-of-function
manipulations in vitro in DRG neurons and in vivo for RGCs.
Antagonizing Activin/TGF-b signaling diminished CAST/Ei
axonal growth after injury toward the level found in C57BL/6
mice, whereas, conversely, Activin administered to pre-condi-
tioned C57BL/6 neurons shifted regeneration capacity toward
that present in CAST/Ei mice. The fact that Activin only induced
active growth on myelin in pre-injured C57BL/6 DRG neurons
means that other components induced by the conditioning injury
need to be present for successful growth, components also pro-
vided by exposure to inflammation for RGCs, and we aim in the
future to tease out what these are and how they interact with
Activin.
A primordial function of Activin in the CNS is revealed by fly
brain metamorphosis, a process that involves pruning of larval-
specific dendritic and axonal processes and outgrowth of adult
axonal structures. A genome-wide mutant screen for blockade
of this growth plasticity resulted in only two genes, the
Drosophila Activin serine kinase receptor (baboon) and dSmad2
(Zheng et al., 2003). In addition, the functional involvement of the
two Drosophila Activin co-receptors and dActivin in neuronal re-
modeling has since also been shown (Zheng et al., 2003, 2006).
Genome-wide studies have also found that Activin-A mediates
tail regeneration in the leopard gecko (Gilbert et al., 2013) and
fin re-growth in fish (Jazwinska et al., 2007). Activin can also pro-
mote embryonic chick DRG cell outgrowth (Fang et al., 2012),
and its expression in the adult CNS can be strongly regulated
after injury (Tretter et al., 2000). In the injured CNS Activin
promotes dendritic complexity (Ishikawa et al., 2010), modifying
spine morphology and increasing the number of synaptic
contacts on dendritic spines (Shoji-Kasai et al., 2007). Activin
signaling through Smad2/3 is therefore a conserved neural/
tissue-regenerative pathway in flies, fish, and birds, and as we
now show, the pathway is also activated in the injured adult
mammalian nervous system in amouse strain in which, uniquely,
substantial central axon regeneration can occur.
In conclusion, we have found that injured neurons in the
mammalian CNS can unexpectedly mount a large regenerative
response and show a central role for Activin signaling in medi-
ating this, providing potential therapeutic opportunity for stroke
and other forms of traumatic brain injury where injury and a prim-
ing inflammation co-exist. Identification of the regenerative
potential of injured CNS neurons in the CAST/Ei strain provides1224 Neuron 86, 1215–1227, June 3, 2015 ª2015 Elsevier Inc.an opportunity to begin to exhaustively interrogate molecular
mechanisms that may enable CNS regeneration in mammals.
EXPERIMENTAL PROCEDURES
Additional information can be found in Supplemental Information.
Mice
All strains of mice were purchased from Jackson Laboratory (Bar Harbor). All
animal experiments except those detailed in Figure 4 (stroke model) were con-
ducted according to institutional animal care and safety guidelines at Boston
Children’s Hospital and Harvard Medical School. Stroke model animals were
used in accordance with the University of California, Los Angeles Chancellor’s
Animal Research Committee.
Sciatic Nerve Crush
Sciatic nerve crush was performed by exposing the left sciatic nerve at the
level of sciatic notch and crushing with smooth forceps for 30 s.
Primary Dissociated DRG Cultures
For pre-conditioned DRG cultures, ipsilateral L4/L5 DRGs were collected
5 days after a sciatic nerve crush. Appropriate L4/L5 DRGs from five mice
(naive or pre-conditioned) were pooled and processed in one tube per exper-
iment as in Ma et al. (2011) and Seijffers et al. (2007). Once dissociated, 3,000
cells were grown per chamber in an eight-well slide, coated with myelin
(100 ng/well) or CSPGs (20 ng/well, Millipore), and 1,500 cells were grown
on laminin (5 mg/well, Invitrogen).
Neurite Growth Assays
For quantification of sensory neuron culture experiments, neurons were plated
in eight-well chamber slides. For data given in Figures 1A–1C, nine non-overlap-
ping low-power (43) microscope images were taken per well, and at least four
wells were assayedper condition. All neurons in these imageswere analyzed by
NeuroMath software. Neurons with neurites exceeding 50 mm were defined as
sprouting cells, and the top 10% of the longest neurite lengths were quantified
to obtain an average score; three independent experiments were performed.
The values shown are the averages of these experiments and SEM (n = 3). For
data given in Figures 1D and 1E, all neurons in at least four chambers of an
eight-well slide were counted. Images were collected with ImageXpress Micro
High-Content Systems, and neurite outgrowth was automatically quantified
using the MetaXpress software.
Activin In Vitro Gain- and Loss-of-Function Experiments
For gain-of-function experiments, either 10 ng/ml of recombinant Activin A, B,
and AB (R&D Systems) or PBS containing 0.1% BSA was added into myelin-
coated eight-chamber slides with 3,000 naive or pre-conditioned C57BL/6
sensory neurons. For loss-of-function experiments, 3,000 naive and pre-
conditioned CAST/Ei sensory neurons were cultured on myelin-coated wells
for 24 hr in 100 nM SB-431542 (Tocris) in 1% final concentration ethanol.
Vehicle control, 1% final volume ethanol.
For nuclear pSmad2/3 counts, C57BL/6 and CAST/Ei DRG naive and pre-
conditioned DRG neurons cultured with or without the presence of either Ac-
tivin or SB-431542 were assayed for nuclear pSmad2/3 expression by immu-
nostaining (Cell Signaling, #8828). Cells were defined as either containing no,
low, or strong pSmad2/3 signal within the nucleus. The percentages of the
cells lacking nuclear pSmad2/3 were compared. The values given are the av-
erages of at least three independent experiments counted blind to treatment.
Spinal Cord Injury
Mice 6 weeks old were anesthetized with a mixture of ketamine/xylazine and
received either sciatic nerve transection or sham operation. At 1 week later,
a T10 laminectomy was performed, and the dorsal half of the spinal cord
was crushed with #5 modified forceps (Dumont, Fine Science Tools). The for-
ceps were deliberately positioned to cut dorsal column axons completely. At
6 weeks after spinal cord injury, axons were traced by injecting 2 ml of 10%mi-
cro-Ruby tracer (3,000 MW, Invitrogen) into the left sciatic nerve. Mice were
kept for an additional 2 weeks before termination. For the quantification of dor-
sal column injury model, the retrogradely labeled axons in a series of regularly
spaced sagittal sections (C57BL/6 n = 5, CAST/Ei n = 7) were imaged, and the
number of regenerating axons at different distances from the lesion epicenter
was normalized to the number of labeled axons caudal (0.5 mm/LS) to the
lesion. The lesion site was defined according to GFAP immunostaining. Trans-
verse sections of the spinal cord (3 mm caudal and 7–8 mm rostral to the
lesion) were taken to confirm the completeness of the lesion and tracing effi-
ciency among experimental groups. Mice with incomplete lesions were
excluded from the analysis. Quantification was performed blinded to the treat-
ment and the mouse strain.
ON Injury
ON crush surgery and intraocular injections were performed under general
anesthesia. The mice received either 6.4 mg or 25 mg of zymosan 5 days prior
and immediately after ON crush into the vitreous. At 5 days prior to sacrifice,
CTB (3 mL, 1%; 103B, List Biological) was injected as an anterograde tracer.
For C57BL/6 control n = 5; 6.4 mg n = 4; 25 mg n = 5. For CAST/Ei control
n = 4; 6.4 mg n = 4; 25 mg n = 6. Quantification was performed blinded to the
treatment and mouse strain.
Quantification of ON Axon Regeneration
At 14 days after ON injury, mice were perfused with saline and 4% PFA.
Regenerating axons were visualized by staining with primary antibodies to
CTB (1:500, GWB-7B96E4, GenWay). Axons were countedmanually in at least
eight longitudinal sections per case at pre-specified distances from the injury
site, and these numbers were converted into the number of regenerating axons
at various distances (Kurimoto et al., 2010).
ON Gain-of-Function Experiment
C57BL/6 mice were injected with 6.4 mg of zymosan 5 days prior to and imme-
diately after ON crush to prime RGCs. The animals were then injected with
either 0.1% BSA or 10 ng/ml of Activin A, B, and AB immediately after ON
crush. A total of five mice were assayed for both control and Activin-treated
groups. Animals were sacrificed 14 days after ON injury, and axonal regener-
ation quantified. Quantification as above was performed blinded to the treat-
ment and mouse strain.
Stroke Model
Strokewas produced in the forelimbmotor cortex as described (Clarkson et al.,
2013; Li et al., 2010; Overman et al., 2012). The neuroanatomical tracer bio-
tinylated dextran amine (BDA) was injected into the motor cortex anterior to
the stroke. The connections labeled by BDA in the ipsilateral hemisphere were
quantified in tangential cortical sections and statistically tested between stroke
andcontrol inCAST/Ei andC57BL/6asdescribed (Clarksonet al., 2013; Li et al.,
2010; Overman et al., 2012). For further details see Supplemental Information.
Microarray Analysis
Total RNA was extracted from naive and injured DRGs (six DRGs per sample,
three mice) across nine strains and assessed with the Agilent Bioanalyzer (Agi-
lent Technologies). A total of four biologically distinct replicates were run per
sample for a total of 72 arrays. Total RNA (200 ng) was amplified, biotinylated,
and hybridized to Illumina MouseRef-8 v2.0 Expression BeadChips. Raw data
were analyzed using Bioconductor packages. Normalized expression values
were used to compute Pearson correlations with phenotypic data.
RNA-Seq Analysis
Readswere quality controlled using FastQC,mapped to the reference genome
using Bowtie2 (Langmead et al., 2009), and counted using summarizeOverlaps
from the GenomicRanges package, and genes were called differentially ex-
pressed using edgeR (Robinson et al., 2010). We searched for genes whose
expression is significantly increased after pre-conditioning injury in the DBA/
2 and CAST/Ei strain to specifically select for genes responsible for the
medium-low to strong growth phenotype using methods described in Supple-
mental Information. This resulted in a list of 16 genes for which we plotted the
expression fold change (compared to the C57BL/6 naive expression level)
across all six conditions.Time Course of Expression of Inhba, Inhbb, and Activin Receptor
Subtype Transcripts
Ipsilateral L4/L5 DRGs were dissected from naive mice and 1, 3, 5, 10, and
14 days post-sciatic nerve crush for both C57BL/6 and CAST/Ei. Each RNA
sample was three animals pooled or six DRGs. A total of four distinct samples
that were collected for naive (n = 4) and three distinct samples for injured DRGs
(n = 3) for each time point were analyzed by QRT-PCR; mean fold change ±
SEM normalized to naive C57BL/6 values. For the quantification of mRNA
expression of the retina in naive, post ON crush, and post ON crush with
6.4 mg zymosan- and 25 mg zymosan-treated C57BL/6 and CAST/Ei, three ret-
inas were pooled per RNA sample. Three independent RNA samples were
analyzed by qRT-PCR (n = 3); mean fold change ± SEM normalized to naive
C57BL/6 values.
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